Overdiagnosis and Breast Cancer Screening Decisions
- Conditions
- Mammography ScreeningGeriatricsDecision Aid
- Registration Number
- NCT07071415
- Lead Sponsor
- Yale University
- Brief Summary
This is a survey-based study using an online panel. The goal of the study is to understand whether information about overdiagnosis influences breast cancer screening intention among older women. Participants are first asked a series of questions about breast cancer screening including their intention to continue screening, knowledge of screening, and beliefs about screening. They are then shown one of three videos about breast cancer screening that contain information about overdiagnosis or a fourth control video that is identical but contains no information about overdiagnosis. Participants are then again asked about screening intention, along with knowledge of screening, overdiagnosis, and questions around trust.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 300
- 70 and older
- Able to participate in an English-language web-based survey
- Prior history of breast cancer or ductal carcinoma in situ
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Participants intention to screen Day 1 Intention to screen, measured on a 15 point scale. Total score range 1-15, lower score means less likely to screen.
- Secondary Outcome Measures
Name Time Method Knowledge of breast cancer screening Day 1 Knowledge of screening will be quantified as the proportion of correct answers out of a total possible 7 questions in the pre test and 11 questions in the post test.
Understanding of overdiagnosis Day 1 Understanding of overdiagnosis will be quantified as proportion of correct responses out of 3 questions about overdiagnosis.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Yale School of Medicine
🇺🇸New Haven, Connecticut, United States
Yale School of Medicine🇺🇸New Haven, Connecticut, United StatesIlana Richman, MDContact203 737 1024ilana.richman@yale.edu